D. Western Therapeutics Institute Inc
6DW
Company Profile
Business description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
Contact
7th Floor, 18 KT Bulding
1-18-11, Nishiki, Naka-ku
Aichi
Nagoyashi460-0003
JPNT: +81 52218785
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
21
Stocks News & Analysis
stocks
Our view of ANZ’s strategic plan
Trying to please customers and shareholders with a simpler and leaner bank.
stocks
Perplexing buyback from overvalued ASX share
Earnings continue to grow but investor expectations are too high.
stocks
Most popular shares in SMSFs
With data showing the continued rise of SMSFs, we explore the top stock picks of individual investors
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,287.20 | 10.10 | 0.11% |
| CAC 40 | 7,919.62 | 14.64 | -0.18% |
| DAX 40 | 24,236.94 | 150.99 | -0.62% |
| Dow JONES (US) | 46,270.46 | 202.88 | 0.44% |
| FTSE 100 | 9,452.77 | 9.90 | 0.10% |
| HKSE | 25,441.35 | 448.13 | -1.73% |
| NASDAQ | 22,521.70 | 172.91 | -0.76% |
| Nikkei 225 | 46,847.32 | 1,241.48 | -2.58% |
| NZX 50 Index | 13,315.09 | 38.10 | 0.29% |
| S&P 500 | 6,644.31 | 10.41 | -0.16% |
| S&P/ASX 200 | 8,979.60 | 10.90 | 0.12% |
| SSE Composite Index | 3,865.23 | 24.27 | -0.62% |